These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 17472698)

  • 81. Methamphetamine increases dopamine release in the nucleus accumbens through calcium-dependent processes.
    Yorgason JT; Hedges DM; Obray JD; Jang EY; Bills KB; Woodbury M; Williams B; Parsons MJ; Andres MA; Steffensen SC
    Psychopharmacology (Berl); 2020 May; 237(5):1317-1330. PubMed ID: 31965252
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The roles of K
    Liang M; Chen G; Xi Z; Qian H; Shang Q; Gao B; An R; Shao G; Wang Z; Wang J; Xiao J; Li T; Liu X
    Neurosci Lett; 2023 Jan; 792():136952. PubMed ID: 36336087
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Blockade of M1 muscarinic acetylcholine receptors modulates the methamphetamine-induced psychomotor stimulant effect.
    Lee KW; Tian YH; You IJ; Kwon SH; Ha RR; Lee SY; Kim HC; Jang CG
    Neuroscience; 2008 Jun; 153(4):1235-44. PubMed ID: 18455881
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The circadian gene, Per2, influences methamphetamine sensitization and reward through the dopaminergic system in the striatum of mice.
    Kim M; Custodio RJ; Botanas CJ; de la Peña JB; Sayson LV; Abiero A; Ryoo ZY; Cheong JH; Kim HJ
    Addict Biol; 2019 Sep; 24(5):946-957. PubMed ID: 30091820
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cannabidiol modulates the METH-induced conditioned place preference through D2-like dopamine receptors in the hippocampal CA1 region.
    Hassanlou AA; Jamali S; RayatSanati K; Mousavi Z; Haghparast A
    Brain Res Bull; 2021 Jul; 172():43-51. PubMed ID: 33862125
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Altered dopamine D1 and D2 receptor mRNA expression in mesencephalon from mice exposed to repeated treatments with methamphetamine and cannabinoid CB1 agonist methanandamide.
    Landa L; Jurajda M; Sulcova A
    Neuro Endocrinol Lett; 2012; 33(4):446-52. PubMed ID: 22936253
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Lack of dopamine D4 receptor participation in mouse hyperdopaminergic locomotor response.
    Liao IM; Chen JC
    Behav Brain Res; 2021 Jan; 396():112925. PubMed ID: 32971195
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Tipepidine increases dopamine level in the nucleus accumbens without methamphetamine-like behavioral sensitization.
    Hamao K; Kawaura K; Soeda F; Hamasaki R; Shirasaki T; Takahama K
    Behav Brain Res; 2015 May; 284():118-24. PubMed ID: 25687844
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Methamphetamine-induced changes in the striatal dopamine pathway in μ-opioid receptor knockout mice.
    Park SW; Shen X; Tien LT; Roman R; Ma T
    J Biomed Sci; 2011 Nov; 18(1):83. PubMed ID: 22074218
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Interrupted expression of NAC-1 augments the behavioral responses to cocaine.
    Kalivas PW; Duffy P; Mackler SA
    Synapse; 1999 Aug; 33(2):153-9. PubMed ID: 10400893
    [TBL] [Abstract][Full Text] [Related]  

  • 91. mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization.
    Shen X; Purser C; Tien LT; Chiu CT; Paul IA; Baker R; Loh HH; Ho IK; Ma T
    J Neurosci Res; 2010 Aug; 88(10):2294-302. PubMed ID: 20209629
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine.
    Ito C; Onodera K; Sakurai E; Sato M; Watanabe T
    J Pharmacol Exp Ther; 1996 Oct; 279(1):271-6. PubMed ID: 8859003
    [TBL] [Abstract][Full Text] [Related]  

  • 93. NR2B subunit of NMDA receptor at nucleus accumbens is involved in morphine rewarding effect by siRNA study.
    Kao JH; Huang EY; Tao PL
    Drug Alcohol Depend; 2011 Nov; 118(2-3):366-74. PubMed ID: 21601998
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Mithramycin protects against dopaminergic neurotoxicity in the mouse brain after administration of methamphetamine.
    Hagiwara H; Iyo M; Hashimoto K
    Brain Res; 2009 Dec; 1301():189-96. PubMed ID: 19748494
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Nicotine- and methamphetamine-induced dopamine release evaluated with in-vivo binding of radiolabelled raclopride to dopamine D2 receptors: comparison with in-vivo microdialysis data.
    Kim SE; Han SM
    Int J Neuropsychopharmacol; 2009 Jul; 12(6):833-41. PubMed ID: 19154629
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse.
    Narita M; Miyatake M; Narita M; Shibasaki M; Shindo K; Nakamura A; Kuzumaki N; Nagumo Y; Suzuki T
    Neuropsychopharmacology; 2006 Nov; 31(11):2476-88. PubMed ID: 16407899
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Neonatal brain inflammation enhances methamphetamine-induced reinstated behavioral sensitization in adult rats analyzed with explainable machine learning.
    Wang KC; Ojeda NB; Wang H; Chiang HS; Tucci MA; Lee JW; Wei HC; Kaizaki-Mitsumoto A; Tanaka S; Dankhara N; Tien LT; Fan LW
    Neurochem Int; 2024 Jun; 176():105743. PubMed ID: 38641026
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Lamotrigine blocks repeated high-dose methamphetamine-induced behavioral sensitization to dizocilpine (MK-801), but not methamphetamine in rats.
    Nakato Y; Abekawa T; Inoue T; Ito K; Koyama T
    Neurosci Lett; 2011 Oct; 504(2):131-134. PubMed ID: 21945544
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: an in vivo microdialysis study.
    Nagai T; Kitahara Y; Shiraki A; Hikita T; Taya S; Kaibuchi K; Yamada K
    Neurosci Lett; 2010 Feb; 470(2):134-8. PubMed ID: 20045719
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Sexual satiety modifies methamphetamine-induced locomotor and rewarding effects and dopamine-related protein levels in the striatum of male rats.
    Violante-Soria V; Cruz SL; Rodríguez-Manzo G
    Psychopharmacology (Berl); 2023 Apr; 240(4):797-812. PubMed ID: 36745226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.